PortfoliosLab logoPortfoliosLab logo
BIO vs. SPY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BIO vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bio-Rad Laboratories, Inc. (BIO) and State Street SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BIO achieves a 1.04% return, which is significantly lower than SPY's 11.69% return. Over the past 10 years, BIO has underperformed SPY with an annualized return of 7.52%, while SPY has yielded a comparatively higher 15.57% annualized return.


BIO

1D
0.22%
1M
19.33%
YTD
1.04%
6M
-3.90%
1Y
41.36%
3Y*
-6.32%
5Y*
-12.05%
10Y*
7.52%

SPY

1D
0.14%
1M
5.40%
YTD
11.69%
6M
12.09%
1Y
29.62%
3Y*
22.64%
5Y*
14.20%
10Y*
15.57%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BIO vs. SPY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BIO
Bio-Rad Laboratories, Inc.
1.04%-7.77%1.74%-23.21%-44.35%29.61%57.54%59.34%-2.70%30.94%
SPY
State Street SPDR S&P 500 ETF
11.69%17.72%24.89%26.18%-18.18%28.73%18.33%31.22%-4.57%21.71%

Correlation

The correlation between BIO and SPY is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.34

Correlation (3Y)
Calculated over the trailing 3-year period

0.38

Correlation (5Y)
Calculated over the trailing 5-year period

0.46

Correlation (10Y)
Calculated over the trailing 10-year period

0.49

Correlation (All Time)
Calculated using the full available price history since Feb 1, 1993

0.42

The correlation between BIO and SPY shifts across timeframes, from 0.34 (1 year) to 0.49 (10 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BIO vs. SPY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIO
BIO Risk / Return Rank: 6868
Overall Rank
BIO Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
BIO Sortino Ratio Rank: 6969
Sortino Ratio Rank
BIO Omega Ratio Rank: 6969
Omega Ratio Rank
BIO Calmar Ratio Rank: 6464
Calmar Ratio Rank
BIO Martin Ratio Rank: 6565
Martin Ratio Rank

SPY
SPY Risk / Return Rank: 7575
Overall Rank
SPY Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
SPY Sortino Ratio Rank: 7575
Sortino Ratio Rank
SPY Omega Ratio Rank: 7676
Omega Ratio Rank
SPY Calmar Ratio Rank: 6868
Calmar Ratio Rank
SPY Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIO vs. SPY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BIOSPYDifference

Sharpe ratio

Return per unit of total volatility

1.01

2.52

-1.51

Sortino ratio

Return per unit of downside risk

1.73

3.42

-1.69

Omega ratio

Gain probability vs. loss probability

1.23

1.46

-0.23

Calmar ratio

Return relative to maximum drawdown

1.21

3.42

-2.21

Martin ratio

Return relative to average drawdown

2.91

15.93

-13.01

BIO vs. SPY - Sharpe Ratio Comparison

The current BIO Sharpe Ratio is 1.01, which is lower than the SPY Sharpe Ratio of 2.52. The chart below compares the historical Sharpe Ratios of BIO and SPY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BIOSPYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.01

2.52

-1.51

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.32

0.84

-1.16

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.22

0.87

-0.65

Sharpe Ratio (All Time)

Calculated using the full available price history

0.27

0.59

-0.32

Drawdowns

BIO vs. SPY - Drawdown Comparison

The maximum BIO drawdown since its inception was -83.64%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for BIO and SPY.


Loading charts...

Drawdown Indicators


BIOSPYDifference

Max Drawdown

Largest peak-to-trough decline

-83.64%

-55.19%

-28.45%

Max Drawdown (1Y)

Largest decline over 1 year

-28.86%

-8.88%

-19.98%

Max Drawdown (3Y)

Largest decline over 3 years

-48.76%

-18.76%

-30.00%

Max Drawdown (5Y)

Largest decline over 5 years

-73.77%

-24.50%

-49.27%

Max Drawdown (10Y)

Largest decline over 10 years

-73.77%

-33.72%

-40.05%

Current Drawdown

Current decline from peak

-62.93%

0.00%

-62.93%

Average Drawdown

Average peak-to-trough decline

-27.73%

-9.05%

-18.68%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.98%

1.91%

+10.07%

Volatility

BIO vs. SPY - Volatility Comparison

Bio-Rad Laboratories, Inc. (BIO) has a higher volatility of 15.41% compared to State Street SPDR S&P 500 ETF (SPY) at 2.75%. This indicates that BIO's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BIOSPYDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.41%

2.75%

+12.66%

Volatility (6M)

Calculated over the trailing 6-month period

28.44%

8.89%

+19.55%

Volatility (1Y)

Calculated over the trailing 1-year period

41.28%

11.81%

+29.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.26%

17.05%

+20.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.03%

17.94%

+16.09%

Dividends

BIO vs. SPY - Dividend Comparison

BIO has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 0.97%.


PositionTTM20252024202320222021202020192018201720162015
BIO
Bio-Rad Laboratories, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
State Street SPDR S&P 500 ETF
0.97%1.07%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%

Frequently Asked Questions


BIO and SPY have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BIO has higher volatility (15.41%) compared to SPY (2.75%). In terms of maximum drawdown, BIO dropped -83.64% vs SPY's -55.19%.

SPY currently has the higher Sharpe Ratio (2.52 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BIO and SPY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer